CanaQuest Medical Corp.

CANQFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$2121

P/E Ratio—

52W High$0.0193

52W Low$0.0001

Avg Volume3

Open$0.00

Beta-0.42

Free Cash Flow Financials Revenue

CanaQuest Medical Corp. (CANQF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CANQF · free cash flow · updated Jun 9, 2026

Core FCF metrics

CANQF · FCF · TTM · margin & CAGR

Free cash flow was −$370,775 for FY2024 (fiscal year ending 2024-03-31), up 44.2% year-over-year The FCF margin was -807.0%.

FY2024 Free Cash Flow−$370,775▲ +44.2% YoY

Trailing 12M (TTM)−$113,324trailing 4 quarters sum

FCF Margin-807.0%−$370,775 ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CANQF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2024Latest−$370,777.2(0M)−$370,775▲ +44.2%-807.0%

FY2023−$660,040(0M)−$664,097▼ 160.9%—

FY2022−$238,466(0M)−$254,572▼ 185.6%—

FY2021−$87,322(0M)−$89,128▼ 83.5%—

FY2020−$48,570(0M)−$48,570▲ +95.5%-166.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CANQF · P/FCF · FCF yield · FCF per share

CanaQuest Medical Corp. (CANQF) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2024 · 2024-03-31

Cash flow statement summary

CANQF · cash flow statement · operating / investing / financing

For FY2024, CanaQuest Medical Corp. generated −$0.4M in operating cash flow and spent 0M in capital expenditures, yielding −$0.4M in free cash flow.

Operating Activities

−$0.4M

Cash from core business operations

2024-03-31

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2024-03-31

Financing Activities

+$0.4M

Buybacks, dividends & debt

2024-03-31

FCF FormulaOperating CF (−$0.4M) − |CapEx| (0M) = FCF (−$0.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CANQF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CanaQuest Medical Corp.YOU

CANQF

−$370,775+44.2%-807.0%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CanaQuest Medical Corp. (CANQF) reported free cash flow of −$370,775 for FY2024 (fiscal year ending 2024-03-31), up 44.2% year-over-year. The FCF margin was -807.0%.

Based on available data, CanaQuest Medical Corp. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $27,539 in FY2018.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CANQF free cash flow · 8 questions

CanaQuest Medical Corp. free cash flow was −$370,775 for FY2024, up 44.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$113,324.

CANQF free cash flowCANQF FCFCANQF FCF 2024CANQF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CanaQuest Medical Corp. · CanaQuest Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026